 CollPlant NASDAQ: CLGN the Company, a regenerative and aesthetic medicine company, announced it has entered into definitive agreements for up to 4.45 million. The capital raise is by way of a non-brokered private placement with U.S. accredited investors who have many years of deep experience in medical and 3D printing. 